Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Dec 12, 2022
Date Accepted: May 5, 2023

The final, peer-reviewed published version of this preprint can be found here:

Sexual Health and Drug Use Prevention for Black Girls (The Dreamer Girls Project): Protocol for an Intervention Development

Opara I, Gabriel C, Duran-Becerra B, Bond K, Hill A, Hussett-Richardson S, Alves C, Kershaw T

Sexual Health and Drug Use Prevention for Black Girls (The Dreamer Girls Project): Protocol for an Intervention Development

JMIR Res Protoc 2023;12:e45007

DOI: 10.2196/45007

PMID: 37556188

PMCID: 10448282

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Study Protocol for The Dreamer Girls Project: A Race & Gender Specific HIV/AIDS, STI, and Drug Use Prevention Intervention for Black Adolescent Girls

  • Ijeoma Opara; 
  • Cora Gabriel; 
  • Beatriz Duran-Becerra; 
  • Keosha Bond; 
  • Ashley Hill; 
  • Sydney Hussett-Richardson; 
  • Courtnae Alves; 
  • Trace Kershaw

ABSTRACT

Background:

Substance use among adolescent girls is associated with numerous risk characteristics including engaging in sexual risk behaviors which can lead to HIV and STI diagnoses. Unfortunately, Black girls have a higher diagnosis of STIs and face a significant “gender paradox” where although they are less likely to use substances than boys and other ethnic-minority girls, they tend to face more negative health consequences from use.

Objective:

We propose the development of a HIV and drug use strengths-based prevention education intervention for Black girls to promote protective factors and challenge negative stereotypes in Black girls.

Methods:

A sequential, mixed methods, pilot feasibility trial will be conducted. Aim 1 is to explore risk and protective factors in drug use and HIV prevention using mixed methods. Aim 2 is to develop and conduct pilot study to determine if the intervention is feasible and acceptable for HIV and drug use prevention in 20 Black adolescent girls.

Results:

The study is part of a 2-year research pilot study award that received funding from the National Institutes of Mental Health. Data collection for this study began October 2021. The remaining year will focus on completing data collection, analysis, dissemination, and developing the intervention components. Moreover, aim 1 data collection is 95% complete. We expect to complete all data collection for aim 1 on or before May 30, 2023. Recruitment for aim 2 will begin Summer 2023.

Conclusions:

This study will be one of the few interventions that address sexual health and drug use specifically for Black girls. We anticipate that the intervention will be beneficial for Black girls across the nation to work on building culturally appropriate prevention education and building peer social supports, resulting in reduction or delayed substance use and improved sexual health. Clinical Trial: ClinicalTrials.gov (NCT05014074


 Citation

Please cite as:

Opara I, Gabriel C, Duran-Becerra B, Bond K, Hill A, Hussett-Richardson S, Alves C, Kershaw T

Sexual Health and Drug Use Prevention for Black Girls (The Dreamer Girls Project): Protocol for an Intervention Development

JMIR Res Protoc 2023;12:e45007

DOI: 10.2196/45007

PMID: 37556188

PMCID: 10448282

The author of this paper has made a PDF available, but requires the user to login, or create an account.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.